Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2003
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003US6652479 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
11/20/2003WO2003095637A1 Combination of a growth factor and a protease enzyme
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095451A1 Carbamate-substituted pyrazolopyridines
11/20/2003WO2003094910A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003061696A3 Systems and methods for photodynamic therapy
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003027076A3 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2003000699A8 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002061110A8 Nucleic acid derivatives
11/20/2003WO2002060935A3 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
11/20/2003WO2002055081A3 Use of chelators in the treatment of macular degenerative disease
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216477 Adrenergic blocking agent
11/20/2003US20030216468 Thiol-based NAALADase inhibitors
11/20/2003US20030216431 Antiinflammatory agents; vision defects; antiallergens; topical applying
11/20/2003US20030216430 3, 4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
11/20/2003US20030216427 Amine derivatives for the treatment of apoptosis
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216417 Substituted anilino-quinoline compounds and use thereof
11/20/2003US20030216413 Catecholamine pharmaceutical compositions and methods
11/20/2003US20030216406 Pyrimidine derivatives
11/20/2003US20030216404 Hydroxamic acid derivatives
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030216335 Treating endometriosis by contacting the subject with a nucleic acid that modulates the expression of VEGF, VEGFR1, and/or VEGFR2
11/20/2003US20030216314 Methods of reducing angiogenesis
11/20/2003US20030216290 Methods and compositions of treating and/or preventing diabetic retinopathy with pericyte apoptosis inhibitors
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215448 Compositions and methods for treating hyperimmune response in the eye
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2474947A1 Combination of a growth factor and a protease enzyme
11/19/2003EP1362588A1 Medicinal compositions comprising diclofenac and ornoprostil
11/19/2003EP1362096A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system
11/19/2003EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1362050A1 Pyrimidine derivatives for inhibition of cell-proliferation
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361885A1 Use of $g(g)-gt inhibitors for the treatment of degenerative diseases
11/19/2003EP1361882A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/19/2003EP1265601B1 Method for treating ocular pain
11/19/2003EP1173198B1 Use of a determined hyaluronidase to eliminate corneal scars, opacification and haze
11/19/2003EP1140150B1 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1117401B1 Antibiotic compositions for treatment of the eye
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457256A Eye drops
11/19/2003CN1456350A Eye cyclosporin gel
11/19/2003CN1456296A Tablets for improving vision acuity and nourishing kidney and preparation thereof
11/19/2003CN1456274A Medicine for treating endocrine infiltrative exophthalmos
11/19/2003CN1456186A Eye drop of double rhizoma coptidis
11/19/2003CN1456171A Compound electrolyte intra-ocular flushing liquor
11/19/2003CN1456167A Artificial tear containing phosphatide and preparing method thereof
11/19/2003CN1456161A Eye gel for atropine sulfate
11/19/2003CN1456158A Eye drops of fluconazole
11/19/2003CN1456157A Ophthalmic gel of L-ofloxacin
11/19/2003CN1456156A Ophthalmic gel of marticarpine
11/19/2003CN1127960C Eyesight improving medicine liquid
11/19/2003CN1127955C Medicine for treating immune relative disease of anterior chamber and surface of eye
11/18/2003US6649653 15-fluoro prostaglandins as ocular hypotensives
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea
11/18/2003US6649625 Agent for prophylaxis and treatment of glaucoma
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649195 Eyesight enhanced maintenance composition
11/18/2003CA2274680C Process for manufacturing ophthalmic suspensions
11/13/2003WO2003093485A2 Optimization of transgene expression in mammalian cells
11/13/2003WO2003093272A1 Imidazo-triazine derivatives as ligands for gaba receptors
11/13/2003WO2003093267A1 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093237A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003WO2003092701A2 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
11/13/2003WO2003092696A1 Method for decreasing capillary permeability in the retina
11/13/2003WO2003092693A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 531